Diovan and Symmetrel drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Diovan (valsartan) and Symmetrel (amantadine hydrochloride). Common drug interactions include palpitations among females and blood pressure decreased among males.

The phase IV clinical study analyzes what interactions people have when they take Diovan and Symmetrel. It is created by eHealthMe based on reports of 86 people who take the same drugs from the FDA, and is updated regularly.

What is Diovan?

Diovan has active ingredients of valsartan. It is often used in high blood pressure. eHealthMe is studying from 83,153 Diovan users. Check the latest studies of Diovan.

What is Symmetrel?

Symmetrel has active ingredients of amantadine hydrochloride. It is often used in parkinson's disease. eHealthMe is studying from 3,398 Symmetrel users. Check the latest studies of Symmetrel.



On Jul, 11, 2026

86 people who take Diovan and Symmetrel together, and have interactions are studied.

Diovan and Symmetrel drug interactions.

What are the common drug interactions of Diovan and Symmetrel, by gender? *:

female:

  1. Palpitations (feelings or sensations that your heart is pounding or racing)
  2. Vomiting
  3. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  4. Pneumonia
  5. Anxiety disorder
  6. Arthralgia (joint pain)
  7. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  8. Hypokinesia (decreased bodily movement)
  9. Loss of consciousness
  10. Sinus tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node)

male:

  1. Blood pressure decreased
  2. Alanine aminotransferase increased
  3. Oedema (fluid collection in tissue)
  4. White blood cell count decreased
  5. Dementia (madness)
  6. Depressed level of consciousness
  7. Dysphagia (a condition in which swallowing is difficult or painful)
  8. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  9. Interstitial lung disease
  10. Oxygen saturation decreased

What are the common drug interactions of Diovan and Symmetrel, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Drug level increased
  2. Dysphagia (a condition in which swallowing is difficult or painful)
  3. Fall
  4. Hypoglycaemia (deficiency of glucose in the bloodstream)
  5. Immobile (not moving)
  6. Mitral valve incompetence (inefficient heart valve)
  7. Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
  8. Oedema peripheral (superficial swelling)
  9. Renal failure (kidney dysfunction)
  10. Respiratory failure (inadequate gas exchange by the respiratory system)

60+:

  1. Tremor (trembling or shaking movements in one or more parts of your body)
  2. Blood pressure decreased
  3. Abdominal discomfort
  4. Arthralgia (joint pain)
  5. Chest discomfort
  6. Decreased appetite
  7. Diarrhoea
  8. Discomfort
  9. Electrolyte imbalance
  10. Gastroenteritis (inflammation of stomach and intestine)

What are the existing conditions these people have? *

  1. Cerebral Infarction (less blood supply to brain resulting tissue damage): 14 people, 16.28%
  2. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 12 people, 13.95%
  3. Nausea (feeling of having an urge to vomit): 8 people, 9.30%
  4. Gastritis (inflammation of stomach): 7 people, 8.14%
  5. Insomnia (sleeplessness): 6 people, 6.98%
  6. Dementia (madness): 6 people, 6.98%
  7. Urinary Tract Infection: 5 people, 5.81%
  8. Hyperlipidaemia (presence of excess lipids in the blood): 5 people, 5.81%
  9. Dizziness: 5 people, 5.81%
  10. Depression: 5 people, 5.81%

* Approximation only. Some reports may have incomplete information.

Do you take Diovan and Symmetrel?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Diovan and Symmetrel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Diovan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Symmetrel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Diovan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Symmetrel and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on valsartan and amantadine hydrochloride (the active ingredients of Diovan and Symmetrel, respectively), and Diovan and Symmetrel (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: